The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real-life conditions over a period of one year

Endocrinology, Diabetes & Metabolism
Isabelle ParisIdes M Colin

Abstract

Using the novel FreeStyle Libre (FSL), glucose monitoring (FGM) system becomes increasingly popular among people with type 1 diabetes (T1D) and is associated with less and shorter hypoglycaemic events without deterioration of HbA1c. There are not yet data reporting the impact of FGM in people with T1D in real-life conditions. We sought of evaluating the tolerance, the acceptance and the efficacy of the FGM system in routine medical practice. This 12-month observational study included 120 individuals with T1D evaluated every 3 months. After having been instructed about FGM utilization, participants were trained to optimize the glycaemic control. Participants stopped immediately of measuring capillary blood glucose (2.88 ± 0.12 per day) (mean ± SEM) after having received the first FSL device and the number of scans per day increased up to 8.87 ± 0.58 per day. HbA1c levels decreased from 8.51% ± 0.14% at baseline to 7.77% ± 0.09% after 3 months to slightly increase to 7.92% ± 0.09% at 12 months, in correlation with the number of scans per day. The number (but not the duration) of hypoglycaemic events slightly increased from 16.9 ± 1.44 per month at baseline to 24.0 ± 2.91 per month at 12 months, after reaching a peak of 26.4 ± 2.3...Continue Reading

References

Dec 2, 2014·Diabetes Technology & Therapeutics·Boris P KovatchevMarc D Breton
Jul 15, 2015·Diabetes Technology & Therapeutics·Timothy BaileyShridhara Alva
Dec 22, 2016·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Thomas HaakGerry Rayman
Jan 25, 2017·JAMA : the Journal of the American Medical Association·Roy W BeckUNKNOWN DIAMOND Study Group
Apr 13, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Thomas HaakGerry Rayman
Jun 7, 2017·Diabetes Technology & Therapeutics·Janet B McGill, Andrew Ahmann

❮ Previous
Next ❯

Citations

Nov 2, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Mark EvansAlexander Seibold
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association
Jul 9, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·O MoserUNKNOWN Hypo-RESOLVE Consortium
Jul 27, 2020·Endocrinology, Diabetes & Metabolism·Klavs Würgler Hansen
Mar 25, 2020·Clinical Medicine Insights. Endocrinology and Diabetes·Ayman A Al HayekMohamed A Al Dawish
Dec 15, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ludger RoseAlexander Seibold
Dec 11, 2020·Diabetes Care·UNKNOWN American Diabetes Association
Dec 2, 2020·Primary Care Diabetes·Steven V EdelmanJeremy Pettus
May 28, 2021·Journal of Diabetes Science and Technology·Klavs W Hansen, Bo M Bibby
Jun 30, 2021·Annals of Medicine·Bruce BodeLiana K Billings
Jul 23, 2021·Journal of the Endocrine Society·Carol H Wysham, Davida F Kruger
Sep 22, 2021·Diabetes Technology & Therapeutics·Tim Nolan, Marie Frazzitta
Sep 22, 2021·Diabetes Technology & Therapeutics·Timothy S Bailey, Shridhara Alva
Sep 22, 2021·Diabetes Technology & Therapeutics·Irl B Hirsch, Eden Miller
Oct 1, 2021·Archives of Endocrinology and Metabolism·Juliana Marques SáMaria Joana Santos
Feb 9, 2021·Clinical Diabetes : a Publication of the American Diabetes Association·Clifford J Bailey, James R Gavin

❮ Previous
Next ❯

Software Mentioned

REPLACE
FreeStyle
Ambulatory Glucose profile , [ AGP ]
GraphPad Prism
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.